Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 97 | 174 | 25 | 38 | 40 |
| Cost of Goods | 40 | 64 | 20 | 207 | 25 |
| Gross Profit | 57 | 110 | 5 | -160 | 15 |
| Operating Expenses | 454 | 355 | 264 | 559 | 218 |
| Operating Income | -361 | -194 | -259 | -521 | -191 |
| Interest Expense | 70 | 73 | 43 | 1 | 0 |
| Other Income | 3 | 0 | 0 | -5 | 2 |
| Pre-tax Income | -429 | -267 | -302 | -527 | -189 |
| Net Income Continuous | -429 | -267 | -302 | -527 | -189 |
| Net Income | $-429 | $-267 | $-302 | $-527 | $-189 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $-293 | $-116 | $-198 | $-520 | $-178 |